Automated External Defibrillators (AED) Global Market Report 2024

The automated external defibrillators (aed) market size has grown strongly in recent years. It will grow from $1.71 billion in 2023 to $1.84 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth observed during the historical period can be attributed to factors such as increased awareness and training, government initiatives and regulations, a rising incidence of cardiac arrest cases, a focus on workplace safety, and the implementation of community-based public access programs.

The automated external defibrillators (aed) market size is expected to see strong growth in the next few years. It will grow to $2.38 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth in the forecast period can be attributed to factors such as global health initiatives, the increasing aging population, the expansion of public access programs, corporate social responsibility initiatives, and the adoption of telemedicine and remote monitoring. Additionally, increased training programs contribute to the overall growth. Major trends expected in the forecast period include the development of AEDs with real-time feedback and coaching, the adoption of smart connectivity and remote monitoring, a focus on user-friendly AED designs and interfaces, the implementation of pediatric mode in AEDs, the integration of CPR feedback technology, and the introduction of AEDs with extended battery life.

The anticipated increase in the incidence of cardiac arrests is set to drive the growth of the automated external defibrillator (AED) market. Cardiac arrest, a sudden and life-threatening medical condition where the heart stops beating or beats irregularly, poses a serious health risk. Automated external defibrillators (AEDs) play a crucial role in treating cardiac arrests by administering an electric shock to the heart, restoring a normal rhythm during irregularities. For example, a report from the Australian Institute of Health and Welfare in June 2023 noted a rise in coronary heart disease deaths from 14,100 in 2021 to 14,900 in 2022. This increase underscores the imperative role of AEDs in addressing the growing incidence of cardiac arrests, thereby propelling the AED market's growth.

The expanding geriatric population is expected to contribute significantly to the growth of the automated external defibrillator (AED) market. The geriatric population, typically aged 65 and above, experiences age-related physical and cognitive changes, making them susceptible to health issues. AEDs offer a valuable solution for the elderly, providing rapid automated treatment during sudden cardiac arrests and improving survival rates through timely electric shocks to restore normal heart rhythm. In July 2022, the United States Census Bureau reported a 2.1% increase in the population of individuals aged 65 and above, reaching 57,794,852 from the previous year's figure of 56,229,126. This demographic shift highlights the growing need for AEDs, thus contributing to the market's expansion.

Limited awareness poses a challenge to the automated external defibrillator (AED) market's growth during the forecast period. Insufficient knowledge about AEDs and their crucial role in cardiac emergencies leads to reduced demand for these life-saving devices. Individuals and organizations may overlook the importance of investing in AEDs if they are unaware of their potential to save lives. A study of First Aide Learning course participants revealed that only 12.28% had mastered AED knowledge, and 86.08% of non-medical responders had never undergone AED training, underscoring the need for increased awareness to overcome this hindrance.

Major companies in the automated external defibrillator (AED) market are prioritizing technological advancements, such as REALConnect technology, to provide reliable services. REALConnect is a software platform leveraging cellular, WiFi, GPS, and Bluetooth connectivity to enable seamless communication between devices. In January 2023, Avive Solutions Inc., a US-based technology company specializing in AED development, launched the Avive Connect AED, an FDA-approved device featuring cellular and WiFi connectivity, GPS technology, remote maintenance, and portability. This innovation exemplifies the commitment of market leaders to advancing AED technology and improving patient outcomes during cardiac emergencies.

In August 2021, Avive Solutions Inc. partnered with RapidSOS to enhance the capabilities of their AED and software solutions. The collaboration aimed to integrate AEDs into a broader safety platform, connecting devices, apps, and sensors for safety agents. Avive Solutions Inc. seeks to leverage this partnership to provide effective AED solutions, prevent cardiac arrests, and contribute valuable patient data through an out-of-hospital cardiac arrest (OHCA) response platform.

Major companies operating in the automated external defibrillators (aed) market report are Koninklijke Philips N.V., Asahi Kasei Corporation, Nihon Kohden Corporation, Schiller AG, Stryker Corporation, Biotronik, BPL Medical Technologies, CU Medical System Inc., Mindray Bio-Medical Electronics Co. Ltd., ViVest Medical Technology Co. Ltd., AMI Italia, Physio-Control Corporation, CardiAid, Kestra Medical Technologies Inc., ViVest Medical Technology Co. Ltd., CU Medical System Inc., DefiSign Life Systems Inc., Progetti S.r.l., MRL Inc., HeartSine Technologies Inc., BPL Medical Technologies, CardiAid, M&B Electronic Instruments Inc., Instramed Inc., Metrax GmbH.

North America was the largest region in the automated external defibrillator market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated external defibrillators (aed) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the automated external defibrillator (AED) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

An automated external defibrillator (AED) is a portable medical device specifically designed to analyze the electrical activity of the heart and, if necessary, deliver an electrical shock to restore a normal heart rhythm in the event of sudden cardiac arrest (SCA). AEDs are crucial in cases of life-threatening cardiac arrhythmias, significantly increasing the chances of survival for individuals experiencing sudden cardiac arrest before professional medical help arrives.

The main types of automated external defibrillators are wearable and non-wearable. A wearable AED is designed to detect abnormal heart rhythms and automatically administer an electric shock to restore the heart's normal rhythm. These devices come in various technology types, including semi-automatic and fully automatic, with different size options such as standard and pediatric. AEDs are utilized for various patient types, including adults and children, and are employed by various end-users such as hospitals, public access settings, homecare settings, pre-hospital care, emergency medical service providers, and others.

The automated external defibrillators (AED) market research report is one of a series of new reports that provides automated external defibrillators (AED) market statistics, including automated external defibrillators (AED) industry global market size, regional shares, competitors with a automated external defibrillators (AED) market share, detailed automated external defibrillators (AED) market segments, market trends and opportunities, and any further data you may need to thrive in the automated external defibrillators (AED) industry. This automated external defibrillators (AED) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The automated external defibrillator (AED) market consists of revenues earned by entities by providing services such as maintenance and monitoring, emergency response planning and deployment services, and rental services. The market value includes the value of related goods sold by the service provider or included within the service offering. The automated external defibrillator (AED) market also includes sales of HeartStart automated external defibrillator (AED), Cardiac Science automated external defibrillator (AED), and HeartSine automated external defibrillator (AED). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.